...
机译:体外CDK5 / p25与CDK5 / p35的tau或组蛋白磷酸化动力学没有差异
Departments of Molecular, Cellular, and Developmental Biology University of California, Santa Barbara, CA 93106;
rnDepartments of Molecular, Cellular, and Developmental Biology University of California, Santa Barbara, CA 93106;
rnDepartments of Molecular, Cellular, and Developmental Biology University of California, Santa Barbara, CA 93106;
rnDepartments of Molecular, Cellular, and Developmental Chemistry, University of California, Santa Barbara, CA 93106;
rnDepartments of Molecular, Cellular, and Developmental Chemistry, University of California, Santa Barbara, CA 93106;
rnDepartments of Molecular, Cellular, and Developmental Biology University of California, Santa Barbara, CA 93106;
alzheimer's disease; neurotoxicity; NMR; protein kinase; proteolysis;
机译:p35 / Cdk5和p25 / Cdk5对淀粉样前体蛋白(APP)磷酸化和加工的调节
机译:他莫昔芬通过与p35 / p25相互作用抑制CDK5激酶活性并调节Tau磷酸化的模式。
机译:p35 / Cdk5途径在体外介导可溶性淀粉样β肽诱导的tau磷酸化。
机译:在体外定量体内外推法(QIVIVE)中的体外动力学与体内动力学
机译:新型苯并咪唑和氨基噻唑作为CDK5 / p25小分子抑制剂的设计与合成
机译:体外CDK5 / p25与CDK5 / p35的tau或组蛋白磷酸化动力学没有差异
机译:体外CDK5 / p25与CDK5 / p35的tau或组蛋白磷酸化动力学没有差异